metformin has been researched along with formononetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Qin, A; Wang, J; Wang, L; Zhou, J | 1 |
| Guo, Y; Ren, Q; Wang, Y; Xin, M | 1 |
2 other study(ies) available for metformin and formononetin
| Article | Year |
|---|---|
The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice.
Topics: Animals; Behavior, Animal; Blood Glucose; Cell Line, Tumor; Cognition; Cognition Disorders; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hippocampus; HMGB1 Protein; Humans; Hypoglycemic Agents; Inflammasomes; Inflammation Mediators; Isoflavones; Male; Maze Learning; Memory; Metformin; Mice, Inbred C57BL; Neurons; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Streptozocin; Toll-Like Receptor 4; Weight Loss | 2018 |
Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro.
Topics: Apoptosis; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Female; Growth Inhibitors; Humans; Hypoglycemic Agents; Isoflavones; MCF-7 Cells; Metformin; Phytoestrogens | 2019 |